Valneva Stock Down 3.34% Ahead of Annual Results

Technical Analysis of Valneva's Stock Performance

By losing more than 3% this Thursday, Valneva has fallen below its 20-day moving average, which is at 4.66 euros, a level that had acted as a support zone in recent sessions. However, the price remains above the 50-day moving average (4.32 euros), indicating a medium-term upward trend. The RSI, positioned at 54, suggests a neutral zone, far from overbought or oversold thresholds, indicating no strong directional tension at this stage. Regarding the Bollinger Bands, the stock is now in the lower half of the channel, between 4.26 euros (lower boundary) and 5.05 euros (upper boundary). The identified resistance threshold at 5.08 euros has not been tested in recent days, while the most relevant technical support is around 3.89 euros, significantly below the current price. This technical framework suggests the stock is in a consolidation phase after its strong quarterly performance.

Valneva's Financial Calendar: A Key Short-Term Element

Valneva's financial calendar is a key short-term element: the Franco-Austrian biotechnology group is set to publish its 2025 annual results on Wednesday, March 18, less than a week away. This upcoming event could partly explain the current movements in the stock, as profit-taking is common ahead of significant announcements, especially after a more than 20% increase over three months. The rest of the calendar includes the announcement of the first quarter 2026 results on May 7, followed by the annual general meeting scheduled for June 1. The 2026 half-year results are expected on August 13. It should be noted that the stock's negative beta (-0.19) reflects a very weak inverse correlation with the market, making it a stock with relatively decoupled behavior from the CAC 40, which is currently down 0.39% at 8,010 points during the session. The SBF 120, meanwhile, is down 0.34% at 6,064 points.